These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 13861221)

  • 1. Azaserine resistance in a plasma-cell neoplasm without change in active transport of the inhibitor.
    ANDERSON EP; JACQUEZ JA
    Cancer Res; 1962 Jan; 22():27-37. PubMed ID: 13861221
    [No Abstract]   [Full Text] [Related]  

  • 2. BIOCHEMICAL EFFECTS OF DUAZOMYCIN A IN THE MOUSE PLASMA CELL NEOPLASM 70429.
    ANDERSON EP; BROCKMAN RW
    Biochem Pharmacol; 1963 Dec; 12():1335-54. PubMed ID: 14096421
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the effect of azaserine and azaserine with 6-mercaptopurine on the Yoshida sarcoma].
    YAMAGUCHI H; KURAHORI T; KUSUMOTO G; TERASHITA N; TABUCHI Y; ICHIHARA G; TOKITA Y; IKEDA E; FUKUI S
    Gan; 1956 Dec; 47(3-4):385-6. PubMed ID: 13415049
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutagenic effect of azaserine in relation to azaserine resistance in Escherichia coli.
    IYER VN; SZYBALSKI W
    Science; 1959 Mar; 129(3352):839-40. PubMed ID: 13635022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of uric acid biosynthesis in birds by o-diazoacetyl-L-serine (azaserine) and 6-diazo-5-oxo-L-norleucine (DON).
    KRAKOFF IH; KARNOFSKY DA
    Am J Physiol; 1958 Oct; 195(1):244-50. PubMed ID: 13583156
    [No Abstract]   [Full Text] [Related]  

  • 6. Purine metabolism in bacteria. IV. L-azaserine as an inhibitor.
    GOLLUB EG; GOTS JS
    J Bacteriol; 1956 Dec; 72(6):858-64. PubMed ID: 13398378
    [No Abstract]   [Full Text] [Related]  

  • 7. Teratogenic changes in early chick embryos following administration of antitumor agent; azaserine.
    BLATTNER RJ; WILLIAMSON AP; SIMONSEN L
    Proc Soc Exp Biol Med; 1958 Mar; 97(3):560-4. PubMed ID: 13518335
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of azaserine (o-diazoacetyl-L-serine) on the pyridine nucleotide levels of mouse liver.
    NARROD SA; LANGAN TA; KAPLAN NO; GOLDIN A
    Nature; 1959 Jun; 183(4676):1674-5. PubMed ID: 13666852
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of azaserine and 6-diazo-5-oxo-L-norleucine on the biosynthesis of inosinic acid de novo.
    BUCHANAN JM
    Tex Rep Biol Med; 1957; 15(1):148-53. PubMed ID: 13409287
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential anti-cancer agents--II. A proposed mechanism for the anti-cancer action of L-azaserine and 6-diazo-5-oxo-L-norleucine.
    BAKER BR
    Biochem Pharmacol; 1959 Sep; 2():161-7. PubMed ID: 13795976
    [No Abstract]   [Full Text] [Related]  

  • 11. Mode of action of azaserine on Gaffkya homari.
    AARONSON S
    J Bacteriol; 1959 May; 77(5):548-51. PubMed ID: 13654215
    [No Abstract]   [Full Text] [Related]  

  • 12. Azaserine, a tumor inhibitory antibiotic.
    STOCK CC; REILLY HC; BUCKLEY SM; CLARKE DA; RHOADS CP
    Acta Unio Int Contra Cancrum; 1955; 11(2):186-93. PubMed ID: 13248727
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects on DON (6-diazo-5-oxo-L-norleucine) and azaserine on the sand-dollar embryo.
    KARNOFSKY DA; BEVELANDER G
    Proc Soc Exp Biol Med; 1958 Jan; 97(1):32-7. PubMed ID: 13518172
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative study of optimal medical care with and without azaserine in multiple myeloma.
    HOLLAND JF
    Clin Pharmacol Ther; 1961; 2():22-8. PubMed ID: 13715278
    [No Abstract]   [Full Text] [Related]  

  • 15. Enzymatic degradation of azaserine.
    JACQUEZ JA; SHERMAN JH
    Cancer Res; 1962 Jan; 22():56-61. PubMed ID: 14450824
    [No Abstract]   [Full Text] [Related]  

  • 16. [Azaserine, new antibiotic and antitumor agent].
    FERRARI F
    Boll Chim Farm; 1956 Mar; 95(3):113-20. PubMed ID: 13315627
    [No Abstract]   [Full Text] [Related]  

  • 17. IV. Effect of O-diazoacetyl-L-serine (azaserine) on growth of various mouse and rat tumors.
    SUGIURA K; STOCK CC
    Proc Soc Exp Biol Med; 1955 Jan; 88(1):127-9. PubMed ID: 14357363
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies of a plasma-cell neoplasm of the mouse. I. Characterization of neoplasm 70429, including its sensitivity to various antimetabolites with the rapid development of resistance to azaserine, DON, and N-methylformamide.
    POTTER M; LAW LW
    J Natl Cancer Inst; 1957 Mar; 18(3):413-41. PubMed ID: 13406561
    [No Abstract]   [Full Text] [Related]  

  • 19. PLASMA CELL NEOPLASM ARISING IN A CAF MOUSE. CHARACTERISTICS AND RESPONSE TO CERTAIN CHEMOTHERAPEUTIC AGENTS.
    YANCEY ST
    J Natl Cancer Inst; 1964 Sep; 33():373-82. PubMed ID: 14207853
    [No Abstract]   [Full Text] [Related]  

  • 20. CROSS RESISTANCE AND COLLATERAL SENSITIVITY STUDIES IN CANCER CHEMOTHERAPY.
    HUTCHISON DJ
    Adv Cancer Res; 1963; 7():235-50. PubMed ID: 14153767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.